Formation of Ellagic Acid Precursors in Fragaria
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Caractérisation De La Polarisation Des Macrophages Pulmonaires Humains Et Voies De Régulation Charlotte Abrial
Caractérisation de la polarisation des macrophages pulmonaires humains et voies de régulation Charlotte Abrial To cite this version: Charlotte Abrial. Caractérisation de la polarisation des macrophages pulmonaires humains et voies de régulation. Biologie cellulaire. Université de Versailles-Saint Quentin en Yvelines, 2014. Français. NNT : 2014VERS0033. tel-01326578 HAL Id: tel-01326578 https://tel.archives-ouvertes.fr/tel-01326578 Submitted on 8 Dec 2016 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Université de Versailles Saint Quentin en Yvelines UFR DES SCIENCES DE LA SANTÉ École doctorale GAO "Des génomes aux organismes" Année universitaire 2014 – 2015 N° le 03 novembre 2014 THESE DE DOCTORAT Présentée pour l’obtention du grade de DOCTEUR DE L’UNIVERSITÉ VERSAILLES – SAINT QUENTIN EN YVELINES Spécialité : Biologie cellulaire Par Charlotte ABRIAL Caractérisation de la polarisation des macrophages pulmonaires humains et voies de régulation Composition du jury: Directeur de thèse Pr. DEVILLIER Philippe Rapporteur Dr. FROSSARD Nelly Rapporteur Pr. LAGENTE Vincent Examinateur Dr. TOUQUI Lhousseine Université de Versailles Saint Quentin en Yvelines UFR DES SCIENCES DE LA SANTÉ École doctorale GAO "Des génomes aux organismes" Année universitaire 2014 – 2015 N° THESE DE DOCTORAT Présentée pour l’obtention du grade de DOCTEUR DE L’UNIVERSITÉ VERSAILLES – SAINT QUENTIN EN YVELINES Spécialité : Biologie cellulaire Par Charlotte ABRIAL Caractérisation de la polarisation des macrophages pulmonaires humains et voies de régulation Composition du jury: Directeur de thèse Pr. -
Deutsche Gesellschaft Für Experimentelle Und Klinische Pharmakologie Und Toxikologie E.V
Naunyn-Schmiedeberg´s Arch Pharmacol (2013 ) 386 (Suppl 1):S1–S104 D OI 10.1007/s00210-013-0832-9 Deutsche Gesellschaft für Experimentelle und Klinische Pharmakologie und Toxikologie e.V. Abstracts of the 79 th Annual Meeting March 5 – 7, 2013 Halle/Saale, Germany This supplement was not sponsored by outside commercial interests. It was funded entirely by the publisher. 123 S2 S3 001 003 Multitarget approach in the treatment of gastroesophagel reflux disease – Nucleoside Diphosphate Kinase B is a Novel Receptor-independent Activator of comparison of a proton-pump inhibitor with STW 5 G-protein Signaling in Clinical and Experimental Atrial Fibrillation Abdel-Aziz H.1,2, Khayyal M. T.3, Kelber O.2, Weiser D.2, Ulrich-Merzenich G.4 Abu-Taha I.1, Voigt N.1, Nattel S.2, Wieland T.3, Dobrev D.1 1Inst. of Pharmaceutical & Medicinal Chemistry, University of Münster Pharmacology, 1Universität Duisburg-Essen Institut für Pharmakologie, Hufelandstr. 55, 45122 Essen, Hittorfstr 58-62, 48149 Münster, Germany Germany 2Steigerwald Arzneimittelwerk Wissenschaft, Havelstr 5, 64295 Darmstadt, Germany 2McGill University Montreal Heart Institute, 3655 Promenade Sir-William-Osler, Montréal 3Faculty of Pharmacy, Cairo University Pharmacology, Cairo Egypt Québec H3G 1Y6, Canada 4Medizinische Poliklinik, University of Bonn, Wilhelmstr. 35-37, 53111 Bonn, Germany 3Medizinische Fakultät Mannheim der Universität Heidelberg Institutes für Experimentelle und Klinische Pharmakologie und Toxikologie, Maybachstr. 14, 68169 Gastroesophageal reflux disease (GERD) was the most common GI-diagnosis (8.9 Mannheim, Germany million visits) in the US in 2012 (1). Proton pump inhibitors (PPI) are presently the mainstay of therapy, but in up to 40% of the patients complete symptom control fails. -
An Overview of Therapeutic Effects of Vanillic Acid
1 Plant Archives Vol. 20, Supplement 2, 2020 pp. 3053-3059 e-ISSN:2581-6063 (online), ISSN:0972-5210 AN OVERVIEW OF THERAPEUTIC EFFECTS OF VANILLIC ACID Neha Sharma 1,2,3 , Nishtha Tiwari 1, Manish Vyas 1, Navneet Khurana 1, Arunachalam Muthuraman 2,4 , Puneet Utreja 5,* 1School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India, PIN- 144 411 2Akal College of Pharmacy and Technical Education, Gursagar Mastuana Sahib, Sangrur, Punjab, India, PIN- 148001 3I.K. Gujral Punjab Technical University, Kapurthala, Punjab, India, PIN-144603 4Faculty of Pharmacy, AIMST University, Kedah, Malaysia 5Faculty of Pharmaceutical Sciences, PCTE Group of Institutes, Ludhiana, Punjab, India, PIN-142021 *Corresponding author: [email protected] Abstract Vanillic acid (VA) is a derivative of benzoic acid which is used as a flavouring agent, preservative, and food additive in the food industry. VA is phenolic molecule that is oxidized molecule of vanillin. VA is obtained from the several cereals such as whole grains; herbs; fruits; green tea; juices; beers and wines. It is known to have various pharmacological properties such as antioxidant, anti-inflammatory, immuno-stimulating, neuroprotective, hepatoprotective, cardioprotective, and antiapoptotic. It is reported that Vanillic acid have the potential to attenuates A β1-42-induced cognitive impairment and oxidative stress therefore contributes to treatment of Alzheimer's disease. Now days, work is going on to investigate that how the vanillic acid produces neuroprotective effect via acting on oxidative stress. Vanillic acid is found in abundance in Black sesame pigment which is used as a food supplement for the prevention of Alzheimer's Disease. In this review, we reviewed the neurological effects of vanillic acid. -
ARTICLE Doi: 10.12032/ATR20200603
ARTICLE doi: 10.12032/ATR20200603 Asian Toxicology Research A network pharmacology approach combined with animal experiment to investigate the blood enriching effect of Gei herba Wen-Bi Mu1, 2#, Can-Can Duan1, 2#, Zhi-Ping Zhong1, 2, Kuan Chen1, 2, Jian-Yong Zhang1, 2* 1School of Pharmacy, Zunyi Medical University, Zunyi 563000, China; 2Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563000, China. #Authors contributed equally to this article. *Corresponding to: Jian-Yong Zhang. Zunyi Medical University, No. 6 Xuefu West Road, Xinpu District, Zunyi 563000, China. Email: [email protected]. Highlights (1) A network pharmacology approach and animal experiments were established to explore the nourishing blood effect of Lanbuzheng (Gei herba). (2) The main active components, targets and pathways of Lanbuzheng (Gei herba) of blood deficiency were predicted by network pharmacology. (3) It’s verified that Lanbuzheng (Gei herba) can treat blood deficiency by improving the peripheral blood routine index and organ index in animal experiment. Submit a manuscript: https://www.tmrjournals.com/atr ATR | August 2020 | vol. 2 | no. 3 | 109 doi: 10.12032/ATR20200603 ARTICLE Abstract Background: To explore active components of Lanbuzheng (Gei herba) and its underlying complex mechanism in treating blood deficiency induced by chemotherapy drug based on network pharmacology and mice experimental validation. Methods: Active components of Lanbuzheng (Gei herba) were screened by Lipinski’s rule of five. Targets acted with active components were predicted by PharmMapper database, and targets whose function associated with blood deficiency were screened by Therapeutic Target Database and UniProt. -
Untersuchungen Zur Regulation Der Polyphenolbiosynthese in Der Erdbeerfrucht (Fragaria Ananassa) Mittels Metabolite Profiling
TECHNISCHE UNIVERSITÄT MÜNCHEN Fachgebiet Biotechnologie der Naturstoffe Untersuchungen zur Regulation der Polyphenolbiosynthese in der Erdbeerfrucht (Fragaria ananassa) mittels Metabolite Profiling Ludwig F. M. Ring Vollständiger Abdruck der von der Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften genehmigten Dissertation. Vorsitzende: Univ.-Prof. Dr. B. Poppenberger Prüfer der Dissertation: 1. Univ.-Prof. Dr. W. Schwab 2. Univ.-Prof. Dr. Th. Hofmann 3. Univ.-Prof. Dr. D. R. Treutter Die Dissertation wurde am 17.06.2013 bei der Technischen Universität München eingereicht und durch die Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt am 22.10.2013 angenommen. „… and all the pieces matter“ Lester Freamon, 2002 meiner Familie Danksagung I Danksagung Meinem Doktorvater Prof. Dr. Wilfried Schwab gilt mein besonderer Dank für die Überlassung des Themas und die Möglichkeit an seinem Fachgebiet zu promovieren. Außerdem danke ich ihm für seine immerwährende Unterstützung und seinen ausstrahlenden Optimismus. Bei Prof. Dr. Brigitte Poppenberger, Prof. Dr. Thomas Hofmann und Prof. Dr. Dieter Treutter bedanke ich mich für die Mitarbeit in der Prüfungskommission. Allen Kooperationspartnern des FraGenomics-Projekts, insbesondere Prof. Dr. Juan Muñoz- Blanco, Dr. Beatrice Denoyes-Rothan und Dr. Amparo Monfort, möchte ich für die gute Zusammenarbeit und die fruchtbaren Diskussionen bei den Projekttreffen danken. Prof. Dr. Victoriano Valpuesta danke ich sehr für die Möglichkeit meine Arbeiten zur Proteinanalytik am Department für Molekularbiologie und Biochemie der Universität Málaga durchführen zu können. Seinem gesamten Arbeitskreis danke ich für die herzliche Aufnahme! Gracias a todos los miembros del grupo! Además, les agradesco a Dra. -
Formation of Β-Glucogallin, the Precursor of Ellagic Acid in Strawberry and Raspberry
Journal of Experimental Botany, Vol. 67, No. 8 pp. 2299–2308, 2016 doi:10.1093/jxb/erw036 Advance Access publication 16 February 2016 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) RESEARCH PAPER Formation of β-glucogallin, the precursor of ellagic acid in strawberry and raspberry Katja Schulenburg1, Antje Feller2, Thomas Hoffmann1, Johannes H. Schecker1, Stefan Martens2 and Wilfried Schwab1,* 1 Biotechnology of Natural Products, Technische Univeristät München, Liesel-Beckmann-Str. 1, D-85354 Freising, Germany 2 Department of Food Quality and Nutrition, IASMA Research and Innovation Center, Fondazione Edmund Mach (FEM), Via E. Mach 1, Downloaded from 38010 San Michele all’Adige, (TN), Italy * Correspondence: [email protected] Received 29 September 2015; Accepted 18 January 2016 http://jxb.oxfordjournals.org/ Editor: Hideki Takahashi, Michigan State University Abstract Ellagic acid/ellagitannins are plant polyphenolic antioxidants that are synthesized from gallic acid and have been asso- ciated with a reduced risk of cancer and cardiovascular diseases. Here, we report the identification and characterization at Biblioteca Fondazione Edmund Mach on August 29, 2016 of five glycosyltransferases (GTs) from two genera of the Rosaceae family (Fragaria and Rubus; F.×ananassa FaGT2*, FaGT2, FaGT5, F. vesca FvGT2, and R. idaeus RiGT2) that catalyze the formation of 1-O-galloyl-β-D-glucopyranose (β-glucogallin) the precursor of ellagitannin biosynthesis. The enzymes showed substrate promiscuity as they formed glucose esters of a variety of (hydroxyl)benzoic and (hydroxyl)cinnamic acids. Determination of kinetic values and site- directed mutagenesis revealed amino acids that affected substrate preference and catalytic activity. -
In Silico Prediction of the Mode of Action of Viola Odorata in Diabetes
Hindawi BioMed Research International Volume 2020, Article ID 2768403, 13 pages https://doi.org/10.1155/2020/2768403 Research Article In Silico Prediction of the Mode of Action of Viola odorata in Diabetes Manal Ali Buabeid ,1 El-Shaimaa A. Arafa ,1,2 Waseem Hassan ,3 and Ghulam Murtaza 3 1College of Pharmacy and Health Sciences, Ajman University, Ajman 346, UAE 2Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni Suef 62514, Egypt 3Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, 54000, Pakistan Correspondence should be addressed to Manal Ali Buabeid; [email protected] Received 16 April 2020; Revised 27 June 2020; Accepted 5 October 2020; Published 31 October 2020 Academic Editor: K. H. Mok Copyright © 2020 Manal Ali Buabeid et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. The metabolic syndrome increases the risk of different diseases such as type 2 diabetes. The prevalence of metabolic syndrome has rapidly grown and affected more than 230 million people worldwide. Viola odorata is a traditionally used plant for the treatment of diabetes; however, its mechanism to manage diabetes is still unknown. Purpose. This study was designed to systematically assess the mechanism of action of Viola odorata in diabetes. Methods. An extensive literature search was made to establish an ingredient-target database of Viola odorata. Of these, targets related to diabetes were identified and used to develop a protein-protein interaction network (PPIN) by utilizing the STITCH database. -
In Silico Molecular Docking of Vanillic Acid Against Apoptotic Proteins
Mukt Shabd Journal ISSN NO : 2347-3150 IN SILICO MOLECULAR DOCKING OF VANILLIC ACID AGAINST APOPTOTIC PROTEINS Senthil. J, Janaki Devi. V1, Padma Priya. V1 Ashok. K* and Babu. M*, *1Department of Microbiology and Biotechnology, Faculty of Arts and Science, Bharath Institute of Higher Education and Research, Chennai, Tamil Nadu, India ABSTRACT The present molecular docking study can be useful for the design and development of novel compound having better inhibitory activity against apoptotic proteins (Caspase-3 and Caspase-9). The docking scores were highest for Caspase-9 with 36.471 kcal/mol with the stronger interaction followed by Caspase-3 (36.9 kcal/mol) and the LogP, lower hydrogen bond counts, confirming the capability of the vanillic acid for binding at the active site of the receptor. The results clearly show that the molecular docking mechanism used to detect the novel anticancer inhibitor has been successfully obtained from a natural polyphenolic compound. Keywords: Vanillic acid, Discovery Studio, Caspase-3 and Caspase-9 INTRODUCTION Vanillic acid (4-hydroxy-3-methoxybenzoic acid) (VA) is a polyphenolic dihydroxybenzoic acid compound produced by secondary metabolism in plants and is widely used in the food industry as a flavoring, food additive and preservative and in pharmaceutical industries as analeptic drug (etamivan) (Fig. 1A and B). The pleasant vanilla scent is due to the molecular structure corresponding to the oxidative form of vanillin aldehyde (vanilla). VA can be found in many foods, including rice, wheat, mango, strawberries, sugar cane, herbs and spices, beer, wine, tea and juices [1-30]. Volume IX, Issue V, MAY/2020 Page No : 5267 Mukt Shabd Journal ISSN NO : 2347-3150 Fig. -
Alternative Treatments for Cancer Prevention and Cure [Part 1]
Advances in Pharmacology and Clinical Trials ISSN: 2474-9214 Alternative Treatments for Cancer Prevention and Cure [Part 1] Abdul Kader Mohiuddin* Review Article Secretary & Treasurer Dr M. Nasirullah Memorial Trust, Tejgaon, Dhaka, Bangladesh Volume 4 Issue 4 Received Date: September 02, 2019 *Corresponding author: Abdul Kader Mohiuddin, Secretary & Treasurer Dr M Published Date: October 17, 2019 Nasirullah Memorial Trust, Tejgaon, Dhaka, Bangladesh, Tel: +8802-9110553; Email: DOI: 10.23880/apct-16000168 [email protected] Abstract Many lay people along with some so called “key opinion leaders” have a common slogan “There's no answer for cancer”. Again, mistake delays proper treatment and make situation worse, more often. Compliance is crucial to obtain optimal health outcomes, such as cure or improvement in QoL. Patients may delay treatment or fail to seek care because of high out-of- pocket expenditures. Despite phenomenal development, conventional therapy falls short in cancer management. There are two major hurdles in anticancer drug development: dose-limiting toxic side effects that reduce either drug effectiveness or the QoL of patients and complicated drug development processes that are costly and time consuming. Cancer patients are increasingly seeking out alternative medicine and might be reluctant to disclose its use to their oncology treatment physicians. But there is limited available information on patterns of utilization and efficacy of alternative medicine for patients with cancer. As adjuvant therapy, many traditional medicines shown efficacy against brain, head and neck, skin, breast, liver, pancreas, kidney, bladder, prostate, colon and blood cancers. The literature reviews non-pharmacological interventions used against cancer, published trials, systematic reviews and meta-analyses. -
European Patent Office U.S. Patent and Trademark Office
EUROPEAN PATENT OFFICE U.S. PATENT AND TRADEMARK OFFICE CPC NOTICE OF CHANGES 89 DATE: JULY 1, 2015 PROJECT RP0098 The following classification changes will be effected by this Notice of Changes: Action Subclass Group(s) Symbols deleted: C12Y 101/01063 C12Y 101/01128 C12Y 101/01161 C12Y 102/0104 C12Y 102/03011 C12Y 103/01004 C12Y 103/0103 C12Y 103/01052 C12Y 103/99007 C12Y 103/9901 C12Y 103/99013 C12Y 103/99021 C12Y 105/99001 C12Y 105/99002 C12Y 113/11013 C12Y 113/12012 C12Y 114/15002 C12Y 114/99028 C12Y 204/01119 C12Y 402/01052 C12Y 402/01058 C12Y 402/0106 C12Y 402/01061 C12Y 601/01025 C12Y 603/02027 Symbols newly created: C12Y 101/01318 C12Y 101/01319 C12Y 101/0132 C12Y 101/01321 C12Y 101/01322 C12Y 101/01323 C12Y 101/01324 C12Y 101/01325 C12Y 101/01326 C12Y 101/01327 C12Y 101/01328 C12Y 101/01329 C12Y 101/0133 C12Y 101/01331 C12Y 101/01332 C12Y 101/01333 CPC Form – v.4 CPC NOTICE OF CHANGES 89 DATE: JULY 1, 2015 PROJECT RP0098 Action Subclass Group(s) C12Y 101/01334 C12Y 101/01335 C12Y 101/01336 C12Y 101/01337 C12Y 101/01338 C12Y 101/01339 C12Y 101/0134 C12Y 101/01341 C12Y 101/01342 C12Y 101/03043 C12Y 101/03044 C12Y 101/98003 C12Y 101/99038 C12Y 102/01083 C12Y 102/01084 C12Y 102/01085 C12Y 102/01086 C12Y 103/01092 C12Y 103/01093 C12Y 103/01094 C12Y 103/01095 C12Y 103/01096 C12Y 103/01097 C12Y 103/0701 C12Y 103/08003 C12Y 103/08004 C12Y 103/08005 C12Y 103/08006 C12Y 103/08007 C12Y 103/08008 C12Y 103/08009 C12Y 103/99032 C12Y 104/01023 C12Y 104/01024 C12Y 104/03024 C12Y 105/01043 C12Y 105/01044 C12Y 105/01045 C12Y 105/03019 C12Y 105/0302 -
The Plant Short-Chain Dehydrogenase (SDR) Superfamily: Genome-Wide Inventory and Diversification Patterns
Moummou et al. BMC Plant Biology 2012, 12:219 http://www.biomedcentral.com/1471-2229/12/219 RESEARCH ARTICLE Open Access The Plant Short-Chain Dehydrogenase (SDR) superfamily: genome-wide inventory and diversification patterns Hanane Moummou1,2, Yvonne Kallberg3, Libert Brice Tonfack1,4, Bengt Persson5,6 and Benoît van der Rest1,7* Abstract Background: Short-chain dehydrogenases/reductases (SDRs) form one of the largest and oldest NAD(P)(H) dependent oxidoreductase families. Despite a conserved ‘Rossmann-fold’ structure, members of the SDR superfamily exhibit low sequence similarities, which constituted a bottleneck in terms of identification. Recent classification methods, relying on hidden-Markov models (HMMs), improved identification and enabled the construction of a nomenclature. However, functional annotations of plant SDRs remain scarce. Results: Wide-scale analyses were performed on ten plant genomes. The combination of hidden Markov model (HMM) based analyses and similarity searches led to the construction of an exhaustive inventory of plant SDR. With 68 to 315 members found in each analysed genome, the inventory confirmed the over-representation of SDRs in plants compared to animals, fungi and prokaryotes. The plant SDRs were first classified into three major types —‘classical’, ‘extended’ and ‘divergent’—but a minority (10% of the predicted SDRs) could not be classified into these general types (‘unknown’ or ‘atypical’ types). In a second step, we could categorize the vast majority of land plant SDRs into a set of 49 families. Out of these 49 families, 35 appeared early during evolution since they are commonly found through all the Green Lineage. Yet, some SDR families — tropinone reductase-like proteins (SDR65C), ‘ABA2-like’-NAD dehydrogenase (SDR110C), ‘salutaridine/menthone-reductase-like’ proteins (SDR114C), ‘dihydroflavonol 4-reductase’-like proteins (SDR108E) and ‘isoflavone-reductase-like’ (SDR460A) proteins — have undergone significant functional diversification within vascular plants since they diverged from Bryophytes. -
Systems Pharmacological Approach to Investigate the Mechanism of Acori Tatarinowii Rhizoma for Alzheimer’S Disease
Hindawi Evidence-Based Complementary and Alternative Medicine Volume 2018, Article ID 5194016, 20 pages https://doi.org/10.1155/2018/5194016 Research Article Systems Pharmacological Approach to Investigate the Mechanism of Acori Tatarinowii Rhizoma for Alzheimer’s Disease Zhenyan Song , Fang Yin, Biao Xiang, Bin Lan, and Shaowu Cheng Te Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China Correspondence should be addressed to Shaowu Cheng; [email protected] Received 30 March 2018; Accepted 30 May 2018; Published 27 June 2018 Academic Editor: Ling Yang Copyright © 2018 Zhenyan Song et al. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In traditional Chinese medicine (TCM), Acori Tatarinowii Rhizoma (ATR) is widely used to treat memory and cognition dysfunction. Tis study aimed to confrm evidence regarding the potential therapeutic efect of ATR on Alzheimer’s disease (AD) using a system network level based in silico approach. Study results showed that the compounds in ATR are highly connected to AD-related signaling pathways, biological processes, and organs. Tese fndings were confrmed by compound-target network, target-organ location network, gene ontology analysis, and KEGG pathway enrichment analysis. Most compounds in ATR have been reported to have antifbrillar amyloid plaques, anti-tau phosphorylation, and anti-infammatory efects. Our results indicated that compounds in ATR interact with multiple targets in a synergetic way.